Michael Luther Ph.D Overview
Michael Luther Ph.D General Information
Biography
Dr. Michael Luther serves as Chief Executive Officer & Board Member at STRM.BIO. He has over 37 years' experience as an entrepreneurial scientist and executive in the biopharmaceutical industry including various senior leadership roles ranging from biotech start-ups to global pharmaceutical companies and CROs. In addition to serving as STRM.BIO's CEO, he is currently the managing partner for BioInnovations, LLC where he acts as a board member and consultant for various start up biotech companies. Previously, he led North American Business Development efforts for Astellas as Global Head of Search & Evaluation in Business Development and Astellas Ventures to support Astellas' drug discovery and development efforts. This included over 9 deals signed and 2 NewCo spinouts in less than two years. Before joining Astellas, he was the CEO and founder of Bantam Pharmaceutical, a biotech company focused on the clinical development of cancer therapeutics targeting the mitochondrial stress response pathway and targets. He remains an active advisor and member of the board of directors and their SAB. In other past roles, He was the Senior Vice President for Drug Discovery & Development at Curio and founding CEO for the David H. Murdock Research Institute at the North Carolina Research Campus, a public-private partnership created to accelerate bench to market activities in life sciences. He also has 20 years in various senior executive roles in the global pharmaceutical industry including Vice President and head of global drug discovery divisions for both Merck and GSK. He holds Bachelor of Science degrees from North Carolina State University, a doctorate from St. Louis University School of Medicine, and an MBA from Duke University . He is the author of over 80 publications and patents.
Contact Information
Address
- 251 River Street
- Cambridge, MA 02139
- United States
Michael Luther Ph.D Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| STRM.BIO | Company | Chief Executive Officer & Board Member | Cambridge, MA | Drug Discovery |
Michael Luther Ph.D Board Seats (1)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| STRM.BIO | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Cambridge, MA |
Michael Luther Ph.D Network (14)
Board Members (14)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Dana Devine | STRM.BIO | Self | Cambridge, MA | |
| Jonathan Thon Ph.D | STRM.BIO | Self | Cambridge, MA | |
| STRM.BIO | Self | Cambridge, MA | ||
| STRM.BIO | Boehringer Ingelheim Venture Fund | Cambridge, MA | ||
| STRM.BIO | Delos Capital Partners | Cambridge, MA |
Michael Luther Ph.D FAQs
-
Who is Michael Luther Ph.D?
Dr. Michael Luther serves as Chief Executive Officer & Board Member at STRM.
-
How much does Michael Luther Ph.D typically invest?
Michael Luther Ph.D's median deal size is .
-
What is Michael Luther Ph.D’s main position?
Michael Luther Ph.D’s primary position is Chief Executive Officer & Board Member.
-
How many active board seats does Michael Luther Ph.D hold?
Michael Luther Ph.D holds a board seat in STRM.BIO.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
